🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
LGN
$LGND
🔒 US EquitiesLigand Pharmaceuticals Incorpor
AVG HISTORICAL GAP
+1.35%
MAX GAP RECORD
+14.46%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $LGND
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$LGND
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Oct 29, 2026 Earnings Release 2026-10-29 (UNDETERMINED) |
+0.00%
|
| Aug 06, 2026 Earnings Release 2026-08-06 (UNDETERMINED) |
+0.00%
|
| May 07, 2026 Earnings Release 2026-05-07 (BEFORE OPEN) |
-11.85%
|
| Feb 26, 2026 Earnings Release 2026-02-26 (UNDETERMINED) |
+0.00%
|
| Nov 06, 2025 Earnings Release 2025-11-06 (BEFORE OPEN) |
+2.95%
|
| Aug 07, 2025 Earnings Release 2025-08-07 (UNDETERMINED) |
+0.00%
|
| May 07, 2025 Earnings Release 2025-05-07 (AFTER CLOSE) |
+1.23%
|
| Feb 27, 2025 Earnings Release 2025-02-27 (BEFORE OPEN) |
-2.84%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
4.5%
Bullish Gaps (7)
Bearish Gaps (3)
Neutral / Flat (1)
📖 Intelligence Summary
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗